Preview Mode Links will not work in preview mode


Sep 27, 2021

After explaining a HORRENDOUS mistake made recently by the NABP and the oversight of NAPLEX testing that affected one of our own, we decided it's high time we dove into the controversy around the use of ivermectin against COVID-19. Social media and mainstream news can be confusing, so we tried to summarize while...

Aug 11, 2021

On this episode we were blessed to have on Kyle McCormick, owner/operator of Blueberry Pharmacy, to explain his unique (but traditionally familiar) business model. Blueberry operates on a cost-plus model and DOES NOT ACCEPT INSURANCE. Crazy? Maybe not. Kyle explains why he thinks we need different payment systems...

Jul 6, 2021

The Twittersphere recently noticed that quoted savings on Amazon Pharmacy are a little bit unrealistic. On this episode we break down how a pharmacy's "Usual & Customary" price SHOULD be calculated, what it is used for, and what Amazon's crazy numbers say about their pharmacy business model.


Jul 6, 2021

The COVID-19 pandemic highlighted many weaknesses in the US Drug Supply Chain's dependence on foreign production (similar to toilet paper, masks, etc.). The Biden White House recently announced plans to address supply chain weaknesses to prevent future shortages due to overseas dependence.



May 19, 2021

After a brief hiatus we are back in the studio! Everyone has important life updates to share, Aaron has some interesting learning points about Medicaid rebates, Ryan explains DIR fees, and we check back in with GoodRx's recent stock price woes.


Twitter/Instagram: @EconRx